Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0141 | 0.4646 | 0.7893 |
Schistosoma mansoni | lipoxygenase | 0.0104 | 0.3309 | 0.3473 |
Brugia malayi | glutaminase DH11.1 | 0.0277 | 0.9527 | 1 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0291 | 1 | 1 |
Echinococcus multilocularis | arachidonate 5 lipoxygenase | 0.0176 | 0.5887 | 1 |
Plasmodium vivax | multidomain scavenger receptor, putative | 0.004 | 0.103 | 1 |
Mycobacterium leprae | Probable fructose bisphosphate aldolase Fba | 0.0142 | 0.4679 | 0.5 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0141 | 0.4646 | 0.7893 |
Entamoeba histolytica | fructose-1,6-bisphosphate aldolase, putative | 0.0291 | 1 | 1 |
Loa Loa (eye worm) | doublecortin family protein | 0.004 | 0.103 | 0.0593 |
Echinococcus multilocularis | RUN | 0.004 | 0.103 | 0.175 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0141 | 0.4646 | 0.4877 |
Giardia lamblia | Fructose-bisphosphate aldolase | 0.0291 | 1 | 1 |
Loa Loa (eye worm) | UDP galactose 4'-epimerase | 0.01 | 0.3182 | 0.2975 |
Leishmania major | udp-glc 4-epimerase, putative | 0.0104 | 0.3328 | 1 |
Echinococcus multilocularis | UDP glucose 4 epimerase | 0.01 | 0.3182 | 0.5405 |
Brugia malayi | N-terminal motif family protein | 0.0178 | 0.5981 | 0.6208 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0291 | 1 | 1 |
Treponema pallidum | fructose-bisphosphate aldolase | 0.0291 | 1 | 0.5 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0291 | 1 | 1 |
Brugia malayi | Doublecortin family protein | 0.004 | 0.103 | 0.0912 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0141 | 0.4646 | 0.7893 |
Schistosoma mansoni | UDP-glucose 4-epimerase | 0.01 | 0.3182 | 0.334 |
Schistosoma mansoni | hypothetical protein | 0.004 | 0.103 | 0.1081 |
Onchocerca volvulus | Rap guanine nucleotide exchange factor 1 homolog | 0.0178 | 0.5981 | 1 |
Echinococcus multilocularis | geminin | 0.0164 | 0.5456 | 0.9269 |
Brugia malayi | hypothetical protein | 0.004 | 0.103 | 0.0912 |
Schistosoma mansoni | loxhd1 | 0.004 | 0.103 | 0.1081 |
Trichomonas vaginalis | glutaminase, putative | 0.0277 | 0.9527 | 0.9306 |
Echinococcus granulosus | geminin | 0.0164 | 0.5456 | 0.9269 |
Mycobacterium ulcerans | glutaminase | 0.0277 | 0.9527 | 1 |
Echinococcus granulosus | Polycystic kidney disease protein | 0.004 | 0.103 | 0.175 |
Trypanosoma brucei | UDP-galactose 4-epimerase | 0.0104 | 0.3328 | 1 |
Schistosoma mansoni | polycystin 1-related | 0.004 | 0.103 | 0.1081 |
Loa Loa (eye worm) | hypothetical protein | 0.004 | 0.103 | 0.0593 |
Echinococcus granulosus | lipoxygenase domain containing protein | 0.004 | 0.103 | 0.175 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0291 | 1 | 1 |
Trypanosoma cruzi | UDP-galactose 4-epimerase | 0.01 | 0.3182 | 1 |
Schistosoma mansoni | rab6-interacting | 0.004 | 0.103 | 0.1081 |
Brugia malayi | hypothetical protein | 0.0025 | 0.0495 | 0.034 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0291 | 1 | 1 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0141 | 0.4646 | 0.4596 |
Loa Loa (eye worm) | hypothetical protein | 0.0178 | 0.5981 | 0.6074 |
Schistosoma mansoni | lipoxygenase | 0.0176 | 0.5887 | 0.6179 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0291 | 1 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0141 | 0.4646 | 0.7893 |
Echinococcus multilocularis | Polycystic kidney disease protein | 0.004 | 0.103 | 0.175 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0291 | 1 | 1 |
Echinococcus multilocularis | lipoxygenase domain containing protein | 0.004 | 0.103 | 0.175 |
Loa Loa (eye worm) | glutaminase | 0.0277 | 0.9527 | 1 |
Brugia malayi | hypothetical protein | 0.004 | 0.103 | 0.0912 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0291 | 1 | 1 |
Toxoplasma gondii | UDP-glucose 4-epimerase | 0.01 | 0.3182 | 1 |
Trypanosoma cruzi | UDP-galactose 4-epimerase, putative | 0.01 | 0.3182 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.004 | 0.103 | 0.0593 |
Schistosoma mansoni | hypothetical protein | 0.0164 | 0.5456 | 0.5727 |
Schistosoma mansoni | hypothetical protein | 0.0164 | 0.5456 | 0.5727 |
Echinococcus granulosus | lipoxygenase domain containing protein | 0.004 | 0.103 | 0.175 |
Brugia malayi | UDP galactose 4'-epimerase | 0.01 | 0.3182 | 0.3214 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0141 | 0.4646 | 0.4877 |
Echinococcus granulosus | arachidonate 5 lipoxygenase | 0.0176 | 0.5887 | 1 |
Schistosoma mansoni | glutaminase | 0.0277 | 0.9527 | 1 |
Mycobacterium tuberculosis | Probable fructose-bisphosphate aldolase Fba | 0.0142 | 0.4679 | 0.5 |
Echinococcus granulosus | UDP glucose 4 epimerase | 0.01 | 0.3182 | 0.5405 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0141 | 0.4646 | 0.4877 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0141 | 0.4646 | 0.478 |
Schistosoma mansoni | rab6-interacting | 0.004 | 0.103 | 0.1081 |
Echinococcus multilocularis | lipoxygenase domain containing protein | 0.004 | 0.103 | 0.175 |
Echinococcus granulosus | RUN | 0.004 | 0.103 | 0.175 |
Plasmodium falciparum | LCCL domain-containing protein | 0.004 | 0.103 | 1 |
Loa Loa (eye worm) | glutaminase 2 | 0.0277 | 0.9527 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.